Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.


INTRODUCTION To assess the efficacy and tolerability of palliative split-course concurrent thoracic chemoradiotherapy (CRT) in patients with incurable locally advanced and metastatic non-small cell lung cancer. METHODS All patients with incurable non-small cell lung cancer and symptomatic thoracic disease treated with palliative split-course CRT between… (More)
DOI: 10.1097/COC.0000000000000007


4 Figures and Tables

Slides referencing similar topics